Tamoxifen / Tamoxifeno 20mg
Product Overview
| Generic Name | Tamoxifen / Tamoxifeno 20mg |
| Brand Name(s) | Nolvadex®, Soltamox®, Taxus® |
| Category | Antineoplastic / Cancer |
| Form | 30 Oral Tablets |
| Strength | 20mg |
| Therapeutic Class | Selective estrogen receptor modulator / SERM |
| ATC Code | L02BA01 |
Manufacturing & Regulatory
| Manufacturer | Asofarma, Dr. Reddy's, Mayne Pharma, Teva |
| GMP Compliance | WHO-GMP |
| COFEPRIS | 010.000.3047.00 |
| Free Sale Certificate | Yes, available as COPP/CPP |
Logistics & Export
| MOQ | 10 Units |
| Shelf Life | 24 Months |
| Storage | Store at 20–25 °C |
| Incoterms | EXW, HS 3004.90 / 30049048 |
| Lead Time | 7 - 10 Business Days |
Documentation Available Upon Request
| Certificate of Analysis (PDF) | Yes—lot-specific Certificate of Analysis |
| SDS-Safety Data Sheet (PDF) | Upon Request, not publicly posted |
| CTD Summary (PDF) | CTD from originator; generic use abbreviated formats |
Special Notes
Tamoxifen is an oral SERM used in hormone receptor-positive breast cancer management, including metastatic breast cancer, adjuvant therapy after surgery/radiation, reduction of contralateral breast cancer risk, DCIS risk reduction, and risk reduction in selected high-risk women.